Ap. Knutsen et al., ABNORMAL IN-VITRO THYMOCYTE DIFFERENTIATION IN A PATIENT WITH SEVERE COMBINED IMMUNODEFICIENCY NEZELOFS SYNDROME, Journal of clinical immunology, 16(3), 1996, pp. 151-158
An in vitro coculture model system of CD34+ stem cells and allogenic c
ultured thymic epithelia fragments was used to evaluate thymocyte diff
erentiation in a 9-month-old child of Amish descent with Nezelof syndr
ome. Though the patient's stem cells differentiate to acquire normal e
xpression of CD2 and CD7, later steps of maturation were abnormal. The
re was detectable but reduced expression of CD3 and CD4 phenotypes. CD
44+ expression, however, was markedly reduced. CD44 is an adhesion mol
ecule, interacting with the matrix ligands hyaluronan and fibronectin,
and is expressed early in thymocyte differentiation and subsequently
in mature T cells. It is hypothesized that abnormal expression of CD44
in a variant of severe combined immunodeficiency, Nezelof's syndrome,
interferes with normal thymocyte and thymic epithelial interaction, w
hich leads to abnormal thymocyte differentiation.